MODERN APPROACHES TO NEW VACCINES INCLUDING PREVENTION OF AIDS. SEPTEMBER 14-18, 1988, COLD SPRING HARBOR, NY

Important note: Information in this article was accurate in 1989. The state of the art may have changed since the publication date.

MODERN APPROACHES TO NEW VACCINES INCLUDING PREVENTION OF AIDS. SEPTEMBER 14-18, 1988, COLD SPRING HARBOR, NY

Modern Approaches to New Vaccines Including Prevention of AIDS. September 14-18, 1988, Cold Spring Harbor, NY, 167 p., 1988.. Unique Identifier : AIDSLINE ICDB/89656942
Anonymous; No affiliation given

Abstract: This volume contains abstracts of most of the papers presented at the 1988 Cold Spring Harbor Laboratory meeting on Modern Approaches to New Vaccines, Including Prevention of AIDS. Sessions of the meeting covered immunology, AIDS, virology, parasitology, and bacteriology. Topics include the following: immunodominance of T-cell epitopes, interferon gamma as an immunological adjuvant, characterization of the hepatitis B virus nucleocapsid, a modified 'Pepscan' method for the rapid identification and characterization of T-cell epitopes in protein antigens, host-HIV interactions in AIDS, structure and activities of HIV envelope, HIV-1 trans-regulatory proteins Rev and Nef, infection of human placental tissue by HIV-1, dengue virus vaccine, a structural and antigenic model of the tick-borne encephalitis virus envelope protein E, vaccinia virus, baculovirus, synthetic peptide vaccine for flavivirus immunity, herpes simplex virus, characterization of the adenovirus-4 E3 region, avian-retrovirus-expressed hemagglutinin, immunity in cutaneous leishmaniasis, secreted immunogen of Toxoplasma gondii, antigens associated with Plasmodium species, HIV-1 neutralization, HIV-1 peptides inducing lymphocyte proliferation, rapid whole-blood immunoassay for HIV-1 antibody, malaria vaccine development, feline herpes virus, bovine papillomavirus, poliovirus, T-cell help for B-cell antibody production against rhinovirus peptides, production of recombinant virus-based vaccines, Sendai virus, Rift Valley fever virus, measles virus, rabies virus, feline infectious peritonitis virus, pertussis toxin, and influenzas.

Keywords: Acquired Immunodeficiency Syndrome/IMMUNOLOGY/*PREVENTION & CONTROL Animal Human HIV/*IMMUNOLOGY HIV Antibodies/ANALYSIS HIV Antigens/IMMUNOLOGY Vaccines, Synthetic/*ADMINISTRATION & DOSAGE/IMMUNOLOGY Viral Vaccines/*ADMINISTRATION & DOSAGE/IMMUNOLOGY MONOGRAPH
891230
M89C0827

AEGiS is a 501(c)3, not-for-profit, tax-exempt, educational corporation. AEGiS is made possible through unrestricted funding from Boehringer Ingelheim, Bridgestone/Firestone Charitable Trust, Bristol-Myers Squibb Company, Elton John AIDS Foundation, Gill Foundation, the National Library of Medicine, Quest Diagnostics, Roche and Trimeris, and donations from users like you. Always watch for outdated information. This article first appeared in 1989. This material is designed to support, not replace, the relationship that exists between you and your doctor.

AEGiS presents published material, reprinted with permission and neither endorses nor opposes any material. All information contained on this website, including information relating to health conditions, products, and treatments, is for informational purposes only. It is often presented in summary or aggregate form. It is not meant to be a substitute for the advice provided by your own physician or other medical professionals. Always discuss treatment options with a doctor who specializes in treating HIV.

Copyright ©1980, 1989. AEGiS. All materials appearing on AEGiS are protected by copyright as a collective work or compilation under U.S. copyright and other laws and are the property of AEGiS, or the party credited as the provider of the content. .